Thomas M Seed Selected Research

Radiation Injuries (Radiation Sickness)

7/2021	Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives.
5/2020	Alterations in Tissue Metabolite Profiles with Amifostine-Prophylaxed Mice Exposed to Gamma Radiation.
10/2019	Metabolomic studies in tissues of mice treated with amifostine and exposed to gamma-radiation.
11/2014	Tocols induce G-CSF and mobilise progenitors that mitigate radiation injury.
1/2014	Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure.
7/2012	Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice.
7/2011	Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approaches.
1/2010	Preclinical development of a bridging therapy for radiation casualties.
11/2003	Genistein treatment protects mice from ionizing radiation injury.
6/2003	Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas M Seed Research Topics

Disease

14	Acute Radiation Syndrome 03/2022 - 11/2014
10	Radiation Injuries (Radiation Sickness) 07/2021 - 06/2003
4	Wounds and Injuries (Trauma) 01/2021 - 05/2013
3	Neoplasms (Cancer) 05/2020 - 02/2002
2	Inflammation (Inflammations) 01/2021 - 12/2004
1	Vomiting 01/2017
1	Thrombosis (Thrombus) 07/2011
1	Neutropenia 08/2006
1	Drug-Related Side Effects and Adverse Reactions 11/2005
1	Body Weight (Weight, Body) 11/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2003
1	Shock 02/2003
1	Weight Loss (Weight Reduction) 11/2002
1	Carcinogenesis 02/2002
1	Leukemia 02/2002

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 12/2004
4	Amifostine (Ethyol)FDA LinkGeneric 11/2019 - 11/2005
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015 - 01/2010
3	alpha-Tocopherol FDA Link 06/2014 - 08/2006
2	sodium salt (E)- 4- carboxystyryl- 4- chlorobenzylsulfoneIBA 01/2021 - 07/2012
2	Investigational DrugsIBA 05/2020 - 01/2017
2	Chemokine ReceptorsIBA 11/2014 - 06/2014
1	romiplostim FDA Link 03/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	CBLB502IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	CytokinesIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2015
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2015
1	plerixafor FDA Link 11/2014
1	tocolIBA 11/2014
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 07/2012
1	Oxygen (Dioxygen)IBA 07/2011
1	polyethylene glycol 400IBA 11/2003
1	FlavonoidsIBA 11/2003
1	GenisteinIBA 11/2003
1	Lipoxygenase InhibitorsIBA 09/2003
1	MK-886IBA 09/2003
1	CaspasesIBA 09/2003
1	Dactinomycin (Actinomycin)FDA LinkGeneric 09/2003
1	Biological ProductsIBA 06/2003
1	Sulfhydryl Compounds (Thiols)IBA 02/2003
1	EndotoxinsIBA 02/2003
1	Messenger RNA (mRNA)IBA 02/2002
1	Cobalt-60IBA 02/2002
1	Oncogene Proteins (Oncogene Protein)IBA 02/2002

Therapy/Procedure

1	Radiotherapy 05/2020
1	Drug Therapy (Chemotherapy) 08/2006
1	Injections 11/2002
1	Oral Administration 11/2002